<\/p>\n
Yay\u0131nlanma: <\/span> 26.09.2021– 11:42<\/span><\/time> \/ Son G\u00fcncelleme: <\/span> 26.09.2021 – 13:13<\/span><\/time> <\/span> <\/p>\n<\/p><\/div>\n\nHacettepe \u00dcniversitesi koordinat\u00f6rl\u00fc\u011f\u00fcnde y\u00fcr\u00fct\u00fclen yerli a\u015f\u0131 Turkovac’\u0131n Faz-3 \u00e7al\u0131\u015fmalar\u0131nda bir s\u00fcre g\u00f6rev yap\u0131p ayr\u0131lan Prof. Dr. Murat Akova, daha \u00f6nce Faz-3 \u00e7al\u0131\u015fmalar\u0131nda yer ald\u0131\u011f\u0131 Sinovac ile Turkovac’\u0131 k\u0131yaslad\u0131. Prof. Dr. Akova, Turkovac’ta Faz-3 \u00e7al\u0131\u015fmas\u0131n\u0131n \u015fu anda 5 merkezde binin \u00fczerinde g\u00f6n\u00fcll\u00fc \u00fczerinde devam etti\u011fini s\u00f6yledi. Akova “\u015eu ana kadar bildi\u011fim kadar\u0131yla Turkovac a\u015f\u0131s\u0131nda herhangi bir yan etkiyle kar\u015f\u0131la\u015f\u0131lmad\u0131” dedi.<\/p>\n‘\u00c7ALI\u015eMA DAHA KISA S\u00dcREDE B\u0130TEB\u0130L\u0130R’<\/strong><\/h2>\nAkova, a\u015f\u0131n\u0131n kullan\u0131labilir hale gelmesi i\u00e7in Faz-3 \u00e7al\u0131\u015fmas\u0131n\u0131n olumlu sonu\u00e7lanmas\u0131 gerekti\u011fine dikkat \u00e7ekerek, “E\u011fer Sinovac a\u015f\u0131s\u0131 kadar etkili oldu\u011fu g\u00f6sterilirse, ondan daha az etkili olmad\u0131\u011f\u0131 kan\u0131tlan\u0131rsa o zaman tabii ki Turkovac a\u015f\u0131s\u0131 onay al\u0131r. O zaman da \u00fcretim safhas\u0131na ge\u00e7ilecek. \u0130naktif a\u015f\u0131lar\u0131 \u00fcretmek \u00e7ok kolay de\u011fil. Bunlar zahmetli i\u015fler. B\u00fcy\u00fck miktarda vir\u00fcsle u\u011fra\u015f\u0131yorsunuz. Buradaki en \u00f6nemli basamak bu bilimsel \u00e7al\u0131\u015fman\u0131n a\u015f\u0131 lehine sonu\u00e7lanmas\u0131, a\u015f\u0131n\u0131n ba\u015far\u0131l\u0131 oldu\u011fu g\u00f6sterilmesidir. E\u011fer istenen d\u00fczeyde g\u00f6n\u00fcll\u00fcye ula\u015f\u0131l\u0131rsa, \u00e7al\u0131\u015fma daha k\u0131sa s\u00fcrede bitebilir” dedi.<\/p>\nHacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Murat Akova<\/figcaption><\/figure>\n‘V\u0130R\u00dcS\u00dcN DE\u011e\u0130\u015e\u0130K KES\u0130MLER\u0130NE KAR\u015eI ANT\u0130KOR \u00dcRET\u0130YOR’<\/strong><\/h2>\nAkova, Turkovac a\u015f\u0131s\u0131n\u0131n Sinovac’la e\u015f de\u011fer bir a\u015f\u0131 oldu\u011funa vurgu yaparak “Turkovac a\u015f\u0131s\u0131 en iyi \u015f\u00f6yle k\u0131yaslanabilir; T\u00fcrkiye\u2019de yayg\u0131n kullan\u0131lan Sinovac a\u015f\u0131s\u0131yla e\u015f de\u011fer bir a\u015f\u0131d\u0131r. Ayn\u0131 y\u00f6ntemle haz\u0131rlan\u0131yor. Sinovac a\u015f\u0131s\u0131nda \u00c7in’deki bir hastadan izole edilmi\u015f vir\u00fcs. Buradaki bizim kendi hastalar\u0131m\u0131zdan elde edilen bir vir\u00fcs. Ama bu vir\u00fcs daha \u00f6nceden hi\u00e7 mutasyona u\u011framam\u0131\u015f orijinal vir\u00fcs. \u0130lk salg\u0131n ba\u015flad\u0131\u011f\u0131nda Vuhan’da ortaya \u00e7\u0131kan esas vir\u00fcs. Turkovac a\u015f\u0131s\u0131n\u0131n i\u00e7erisindeki vir\u00fcs de o. Turkovac a\u015f\u0131s\u0131 da inaktif bir a\u015f\u0131. \u0130naktif a\u015f\u0131lar\u0131n \u015f\u00f6yle \u00f6zellikleri var; bunlar mRNA a\u015f\u0131lar\u0131na g\u00f6re, \u00f6rne\u011fin Biontech a\u015f\u0131s\u0131na g\u00f6re ba\u015flang\u0131\u00e7ta daha az miktarda antikor \u00fcretiyorlar. Ama vir\u00fcs\u00fcn de\u011fi\u015fik kesimlerine kar\u015f\u0131 daha yayg\u0131n antikor \u00fcretiyorlar. Genellikle bu a\u015f\u0131lar\u0131n etkileri daha k\u0131sa s\u00fcreli oluyor. Sinovac’ta da g\u00f6rd\u00fc\u011f\u00fcm\u00fcz gibi ikinci dozdan 3-4 ay sonra kandaki antikor d\u00fczeyi azal\u0131p yeni bir hat\u0131rlatma dozu gerekebiliyor. Sinovac a\u015f\u0131s\u0131 i\u00e7in s\u00f6ylenen \u015feylerin hepsi Turkovac a\u015f\u0131s\u0131 i\u00e7in de muhtemelen haz\u0131rlanmas\u0131, etkisi, etkisinin s\u00fcresi a\u00e7\u0131s\u0131ndan s\u00f6ylenebilecek durumlard\u0131r. Benzer sonu\u00e7lar \u00e7\u0131kaca\u011f\u0131n\u0131 tahmin ediyorum. Turkovac a\u015f\u0131s\u0131n\u0131n Sinovac a\u015f\u0131s\u0131 kadar etkili olaca\u011f\u0131n\u0131 tahmin ediyorum” diye konu\u015ftu.<\/p>\n‘ANT\u0130KOR AZALIYOR AMA KORUYUCULU\u011eU DEVAM ED\u0130YOR’<\/strong><\/h2>\nAkova, \u015fu anda Delta varyant\u0131na kar\u015f\u0131 y\u00fczde 100 koruyucu a\u015f\u0131 olmad\u0131\u011f\u0131n\u0131 belirterek “Sinovac’ta da bir s\u00fcre sonra antikor azal\u0131yor ama yine de koruyuculu\u011fu devam ettiriyor. \u015eimdi ayn\u0131 durumun Turkovac a\u015f\u0131s\u0131 i\u00e7in de olmas\u0131 beklenebilir. Asl\u0131nda bu bilimsel \u00e7al\u0131\u015fman\u0131n sonu\u00e7lanmas\u0131 bu a\u00e7\u0131dan da \u00f6nemli \u00e7\u00fcnk\u00fc \u015fu anda T\u00fcrkiye’de hakim olan vir\u00fcs Delta varyant\u0131. Dolay\u0131s\u0131yla her iki a\u015f\u0131n\u0131n Sinovac ve Turkovac a\u015f\u0131s\u0131n\u0131n Delta varyant\u0131na kar\u015f\u0131 koruyucu oldu\u011fu g\u00f6sterilirse ba\u015far\u0131l\u0131 olaca\u011f\u0131 sonucuna varabiliriz. Tabii o sonucu beklemek laz\u0131m” ifadelerini kulland\u0131.<\/p>\n‘A\u015eI YA\u015eININ 2 YA\u015eA KADAR \u0130ND\u0130\u011e\u0130N\u0130 G\u00d6REB\u0130LECE\u011e\u0130Z’<\/strong><\/h2>\nAkova, \u00e7ocuklar\u0131n a\u015f\u0131lanmas\u0131 tart\u0131\u015fmalar\u0131 i\u00e7in de “\u015eu anda d\u00fcnyan\u0131n farkl\u0131 \u00fclkelerinde yap\u0131lan \u00e7al\u0131\u015fmalar var. Bunlardan bir tanesi Pfizer\/BionTech firmas\u0131n\u0131n 5-12 ya\u015f aras\u0131ndaki \u00e7ocuklara a\u015f\u0131 uygulanmas\u0131n\u0131 kapsayan \u00e7al\u0131\u015fma. Hen\u00fcz yay\u0131mlanmad\u0131, o veriler Amerikan Sa\u011fl\u0131k Otoritesi’ne sunuldu. Sonu\u00e7lar\u0131 g\u00f6rmedik. Gerek Amerikan Sa\u011fl\u0131k Otoritesi gerekse bilimsel bir dergide yay\u0131mlan\u0131p hakem ele\u015ftirisinden ge\u00e7tikten sonra bu konuda daha kesin bir yarg\u0131ya varmak m\u00fcmk\u00fcn. \u00d6n izlenim \u00f6yle ki, bu ya\u015f grubunda a\u015f\u0131 etkili ve takip s\u00fcresi i\u00e7erisindeki tabii k\u0131sa s\u00fcreli takip, g\u00fcvenlik ve yan etki a\u00e7\u0131s\u0131ndan ciddi bir sorun yokmu\u015f gibi g\u00f6z\u00fck\u00fcyor. E\u011fer bu kan\u0131tlan\u0131rsa, benzer a\u015f\u0131larla mesela \u00c7in’de yap\u0131lan \u00e7al\u0131\u015fmalar var. Oradaki \u00e7al\u0131\u015fmalarda a\u015f\u0131 ya\u015f\u0131n\u0131n 2 ya\u015fa kadar indi\u011fini g\u00f6r\u00fcyoruz. E\u011fer bunlar da bilimsel olarak kan\u0131tlan\u0131r, ba\u015fka bilim adamlar\u0131n\u0131n ele\u015ftiri s\u00fczgecinden ge\u00e7er ve do\u011fru oldu\u011fu kabul edilirse, o zaman \u00f6yle anla\u015f\u0131l\u0131yor ki k\u0131sa bir s\u00fcre sonra a\u015f\u0131 ya\u015f\u0131n\u0131n 2 ya\u015fa kadar indi\u011fini g\u00f6rebilece\u011fiz. E\u011fer a\u015f\u0131 ya\u015f\u0131 daha da a\u015fa\u011f\u0131 iner ve toplumda yayg\u0131n bir duruma gelirse o zaman pandemi kontrol\u00fcnde \u00f6nemli bir ad\u0131m at\u0131lm\u0131\u015f olacakt\u0131r” diye konu\u015ftu. <\/p>\nKaynak: DHA<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":" Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Murat Akova, Turkovac ile Sinovac’\u0131n e\u015f de\u011fer bir a\u015f\u0131 oldu\u011funu s\u00f6yledi….<\/p>\n","protected":false},"author":2,"featured_media":16450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-16449","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/16449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=16449"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/16449\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/16450"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=16449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=16449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=16449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Hacettepe \u00dcniversitesi koordinat\u00f6rl\u00fc\u011f\u00fcnde y\u00fcr\u00fct\u00fclen yerli a\u015f\u0131 Turkovac’\u0131n Faz-3 \u00e7al\u0131\u015fmalar\u0131nda bir s\u00fcre g\u00f6rev yap\u0131p ayr\u0131lan Prof. Dr. Murat Akova, daha \u00f6nce Faz-3 \u00e7al\u0131\u015fmalar\u0131nda yer ald\u0131\u011f\u0131 Sinovac ile Turkovac’\u0131 k\u0131yaslad\u0131. Prof. Dr. Akova, Turkovac’ta Faz-3 \u00e7al\u0131\u015fmas\u0131n\u0131n \u015fu anda 5 merkezde binin \u00fczerinde g\u00f6n\u00fcll\u00fc \u00fczerinde devam etti\u011fini s\u00f6yledi. Akova “\u015eu ana kadar bildi\u011fim kadar\u0131yla Turkovac a\u015f\u0131s\u0131nda herhangi bir yan etkiyle kar\u015f\u0131la\u015f\u0131lmad\u0131” dedi.<\/p>\n
Akova, a\u015f\u0131n\u0131n kullan\u0131labilir hale gelmesi i\u00e7in Faz-3 \u00e7al\u0131\u015fmas\u0131n\u0131n olumlu sonu\u00e7lanmas\u0131 gerekti\u011fine dikkat \u00e7ekerek, “E\u011fer Sinovac a\u015f\u0131s\u0131 kadar etkili oldu\u011fu g\u00f6sterilirse, ondan daha az etkili olmad\u0131\u011f\u0131 kan\u0131tlan\u0131rsa o zaman tabii ki Turkovac a\u015f\u0131s\u0131 onay al\u0131r. O zaman da \u00fcretim safhas\u0131na ge\u00e7ilecek. \u0130naktif a\u015f\u0131lar\u0131 \u00fcretmek \u00e7ok kolay de\u011fil. Bunlar zahmetli i\u015fler. B\u00fcy\u00fck miktarda vir\u00fcsle u\u011fra\u015f\u0131yorsunuz. Buradaki en \u00f6nemli basamak bu bilimsel \u00e7al\u0131\u015fman\u0131n a\u015f\u0131 lehine sonu\u00e7lanmas\u0131, a\u015f\u0131n\u0131n ba\u015far\u0131l\u0131 oldu\u011fu g\u00f6sterilmesidir. E\u011fer istenen d\u00fczeyde g\u00f6n\u00fcll\u00fcye ula\u015f\u0131l\u0131rsa, \u00e7al\u0131\u015fma daha k\u0131sa s\u00fcrede bitebilir” dedi.<\/p>\nHacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Murat Akova<\/figcaption><\/figure>\n‘V\u0130R\u00dcS\u00dcN DE\u011e\u0130\u015e\u0130K KES\u0130MLER\u0130NE KAR\u015eI ANT\u0130KOR \u00dcRET\u0130YOR’<\/strong><\/h2>\nAkova, Turkovac a\u015f\u0131s\u0131n\u0131n Sinovac’la e\u015f de\u011fer bir a\u015f\u0131 oldu\u011funa vurgu yaparak “Turkovac a\u015f\u0131s\u0131 en iyi \u015f\u00f6yle k\u0131yaslanabilir; T\u00fcrkiye\u2019de yayg\u0131n kullan\u0131lan Sinovac a\u015f\u0131s\u0131yla e\u015f de\u011fer bir a\u015f\u0131d\u0131r. Ayn\u0131 y\u00f6ntemle haz\u0131rlan\u0131yor. Sinovac a\u015f\u0131s\u0131nda \u00c7in’deki bir hastadan izole edilmi\u015f vir\u00fcs. Buradaki bizim kendi hastalar\u0131m\u0131zdan elde edilen bir vir\u00fcs. Ama bu vir\u00fcs daha \u00f6nceden hi\u00e7 mutasyona u\u011framam\u0131\u015f orijinal vir\u00fcs. \u0130lk salg\u0131n ba\u015flad\u0131\u011f\u0131nda Vuhan’da ortaya \u00e7\u0131kan esas vir\u00fcs. Turkovac a\u015f\u0131s\u0131n\u0131n i\u00e7erisindeki vir\u00fcs de o. Turkovac a\u015f\u0131s\u0131 da inaktif bir a\u015f\u0131. \u0130naktif a\u015f\u0131lar\u0131n \u015f\u00f6yle \u00f6zellikleri var; bunlar mRNA a\u015f\u0131lar\u0131na g\u00f6re, \u00f6rne\u011fin Biontech a\u015f\u0131s\u0131na g\u00f6re ba\u015flang\u0131\u00e7ta daha az miktarda antikor \u00fcretiyorlar. Ama vir\u00fcs\u00fcn de\u011fi\u015fik kesimlerine kar\u015f\u0131 daha yayg\u0131n antikor \u00fcretiyorlar. Genellikle bu a\u015f\u0131lar\u0131n etkileri daha k\u0131sa s\u00fcreli oluyor. Sinovac’ta da g\u00f6rd\u00fc\u011f\u00fcm\u00fcz gibi ikinci dozdan 3-4 ay sonra kandaki antikor d\u00fczeyi azal\u0131p yeni bir hat\u0131rlatma dozu gerekebiliyor. Sinovac a\u015f\u0131s\u0131 i\u00e7in s\u00f6ylenen \u015feylerin hepsi Turkovac a\u015f\u0131s\u0131 i\u00e7in de muhtemelen haz\u0131rlanmas\u0131, etkisi, etkisinin s\u00fcresi a\u00e7\u0131s\u0131ndan s\u00f6ylenebilecek durumlard\u0131r. Benzer sonu\u00e7lar \u00e7\u0131kaca\u011f\u0131n\u0131 tahmin ediyorum. Turkovac a\u015f\u0131s\u0131n\u0131n Sinovac a\u015f\u0131s\u0131 kadar etkili olaca\u011f\u0131n\u0131 tahmin ediyorum” diye konu\u015ftu.<\/p>\n‘ANT\u0130KOR AZALIYOR AMA KORUYUCULU\u011eU DEVAM ED\u0130YOR’<\/strong><\/h2>\nAkova, \u015fu anda Delta varyant\u0131na kar\u015f\u0131 y\u00fczde 100 koruyucu a\u015f\u0131 olmad\u0131\u011f\u0131n\u0131 belirterek “Sinovac’ta da bir s\u00fcre sonra antikor azal\u0131yor ama yine de koruyuculu\u011fu devam ettiriyor. \u015eimdi ayn\u0131 durumun Turkovac a\u015f\u0131s\u0131 i\u00e7in de olmas\u0131 beklenebilir. Asl\u0131nda bu bilimsel \u00e7al\u0131\u015fman\u0131n sonu\u00e7lanmas\u0131 bu a\u00e7\u0131dan da \u00f6nemli \u00e7\u00fcnk\u00fc \u015fu anda T\u00fcrkiye’de hakim olan vir\u00fcs Delta varyant\u0131. Dolay\u0131s\u0131yla her iki a\u015f\u0131n\u0131n Sinovac ve Turkovac a\u015f\u0131s\u0131n\u0131n Delta varyant\u0131na kar\u015f\u0131 koruyucu oldu\u011fu g\u00f6sterilirse ba\u015far\u0131l\u0131 olaca\u011f\u0131 sonucuna varabiliriz. Tabii o sonucu beklemek laz\u0131m” ifadelerini kulland\u0131.<\/p>\n‘A\u015eI YA\u015eININ 2 YA\u015eA KADAR \u0130ND\u0130\u011e\u0130N\u0130 G\u00d6REB\u0130LECE\u011e\u0130Z’<\/strong><\/h2>\nAkova, \u00e7ocuklar\u0131n a\u015f\u0131lanmas\u0131 tart\u0131\u015fmalar\u0131 i\u00e7in de “\u015eu anda d\u00fcnyan\u0131n farkl\u0131 \u00fclkelerinde yap\u0131lan \u00e7al\u0131\u015fmalar var. Bunlardan bir tanesi Pfizer\/BionTech firmas\u0131n\u0131n 5-12 ya\u015f aras\u0131ndaki \u00e7ocuklara a\u015f\u0131 uygulanmas\u0131n\u0131 kapsayan \u00e7al\u0131\u015fma. Hen\u00fcz yay\u0131mlanmad\u0131, o veriler Amerikan Sa\u011fl\u0131k Otoritesi’ne sunuldu. Sonu\u00e7lar\u0131 g\u00f6rmedik. Gerek Amerikan Sa\u011fl\u0131k Otoritesi gerekse bilimsel bir dergide yay\u0131mlan\u0131p hakem ele\u015ftirisinden ge\u00e7tikten sonra bu konuda daha kesin bir yarg\u0131ya varmak m\u00fcmk\u00fcn. \u00d6n izlenim \u00f6yle ki, bu ya\u015f grubunda a\u015f\u0131 etkili ve takip s\u00fcresi i\u00e7erisindeki tabii k\u0131sa s\u00fcreli takip, g\u00fcvenlik ve yan etki a\u00e7\u0131s\u0131ndan ciddi bir sorun yokmu\u015f gibi g\u00f6z\u00fck\u00fcyor. E\u011fer bu kan\u0131tlan\u0131rsa, benzer a\u015f\u0131larla mesela \u00c7in’de yap\u0131lan \u00e7al\u0131\u015fmalar var. Oradaki \u00e7al\u0131\u015fmalarda a\u015f\u0131 ya\u015f\u0131n\u0131n 2 ya\u015fa kadar indi\u011fini g\u00f6r\u00fcyoruz. E\u011fer bunlar da bilimsel olarak kan\u0131tlan\u0131r, ba\u015fka bilim adamlar\u0131n\u0131n ele\u015ftiri s\u00fczgecinden ge\u00e7er ve do\u011fru oldu\u011fu kabul edilirse, o zaman \u00f6yle anla\u015f\u0131l\u0131yor ki k\u0131sa bir s\u00fcre sonra a\u015f\u0131 ya\u015f\u0131n\u0131n 2 ya\u015fa kadar indi\u011fini g\u00f6rebilece\u011fiz. E\u011fer a\u015f\u0131 ya\u015f\u0131 daha da a\u015fa\u011f\u0131 iner ve toplumda yayg\u0131n bir duruma gelirse o zaman pandemi kontrol\u00fcnde \u00f6nemli bir ad\u0131m at\u0131lm\u0131\u015f olacakt\u0131r” diye konu\u015ftu. <\/p>\nKaynak: DHA<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":" Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Murat Akova, Turkovac ile Sinovac’\u0131n e\u015f de\u011fer bir a\u015f\u0131 oldu\u011funu s\u00f6yledi….<\/p>\n","protected":false},"author":2,"featured_media":16450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-16449","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/16449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=16449"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/16449\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/16450"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=16449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=16449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=16449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Akova, Turkovac a\u015f\u0131s\u0131n\u0131n Sinovac’la e\u015f de\u011fer bir a\u015f\u0131 oldu\u011funa vurgu yaparak “Turkovac a\u015f\u0131s\u0131 en iyi \u015f\u00f6yle k\u0131yaslanabilir; T\u00fcrkiye\u2019de yayg\u0131n kullan\u0131lan Sinovac a\u015f\u0131s\u0131yla e\u015f de\u011fer bir a\u015f\u0131d\u0131r. Ayn\u0131 y\u00f6ntemle haz\u0131rlan\u0131yor. Sinovac a\u015f\u0131s\u0131nda \u00c7in’deki bir hastadan izole edilmi\u015f vir\u00fcs. Buradaki bizim kendi hastalar\u0131m\u0131zdan elde edilen bir vir\u00fcs. Ama bu vir\u00fcs daha \u00f6nceden hi\u00e7 mutasyona u\u011framam\u0131\u015f orijinal vir\u00fcs. \u0130lk salg\u0131n ba\u015flad\u0131\u011f\u0131nda Vuhan’da ortaya \u00e7\u0131kan esas vir\u00fcs. Turkovac a\u015f\u0131s\u0131n\u0131n i\u00e7erisindeki vir\u00fcs de o. Turkovac a\u015f\u0131s\u0131 da inaktif bir a\u015f\u0131. \u0130naktif a\u015f\u0131lar\u0131n \u015f\u00f6yle \u00f6zellikleri var; bunlar mRNA a\u015f\u0131lar\u0131na g\u00f6re, \u00f6rne\u011fin Biontech a\u015f\u0131s\u0131na g\u00f6re ba\u015flang\u0131\u00e7ta daha az miktarda antikor \u00fcretiyorlar. Ama vir\u00fcs\u00fcn de\u011fi\u015fik kesimlerine kar\u015f\u0131 daha yayg\u0131n antikor \u00fcretiyorlar. Genellikle bu a\u015f\u0131lar\u0131n etkileri daha k\u0131sa s\u00fcreli oluyor. Sinovac’ta da g\u00f6rd\u00fc\u011f\u00fcm\u00fcz gibi ikinci dozdan 3-4 ay sonra kandaki antikor d\u00fczeyi azal\u0131p yeni bir hat\u0131rlatma dozu gerekebiliyor. Sinovac a\u015f\u0131s\u0131 i\u00e7in s\u00f6ylenen \u015feylerin hepsi Turkovac a\u015f\u0131s\u0131 i\u00e7in de muhtemelen haz\u0131rlanmas\u0131, etkisi, etkisinin s\u00fcresi a\u00e7\u0131s\u0131ndan s\u00f6ylenebilecek durumlard\u0131r. Benzer sonu\u00e7lar \u00e7\u0131kaca\u011f\u0131n\u0131 tahmin ediyorum. Turkovac a\u015f\u0131s\u0131n\u0131n Sinovac a\u015f\u0131s\u0131 kadar etkili olaca\u011f\u0131n\u0131 tahmin ediyorum” diye konu\u015ftu.<\/p>\n
Akova, \u015fu anda Delta varyant\u0131na kar\u015f\u0131 y\u00fczde 100 koruyucu a\u015f\u0131 olmad\u0131\u011f\u0131n\u0131 belirterek “Sinovac’ta da bir s\u00fcre sonra antikor azal\u0131yor ama yine de koruyuculu\u011fu devam ettiriyor. \u015eimdi ayn\u0131 durumun Turkovac a\u015f\u0131s\u0131 i\u00e7in de olmas\u0131 beklenebilir. Asl\u0131nda bu bilimsel \u00e7al\u0131\u015fman\u0131n sonu\u00e7lanmas\u0131 bu a\u00e7\u0131dan da \u00f6nemli \u00e7\u00fcnk\u00fc \u015fu anda T\u00fcrkiye’de hakim olan vir\u00fcs Delta varyant\u0131. Dolay\u0131s\u0131yla her iki a\u015f\u0131n\u0131n Sinovac ve Turkovac a\u015f\u0131s\u0131n\u0131n Delta varyant\u0131na kar\u015f\u0131 koruyucu oldu\u011fu g\u00f6sterilirse ba\u015far\u0131l\u0131 olaca\u011f\u0131 sonucuna varabiliriz. Tabii o sonucu beklemek laz\u0131m” ifadelerini kulland\u0131.<\/p>\n
Akova, \u00e7ocuklar\u0131n a\u015f\u0131lanmas\u0131 tart\u0131\u015fmalar\u0131 i\u00e7in de “\u015eu anda d\u00fcnyan\u0131n farkl\u0131 \u00fclkelerinde yap\u0131lan \u00e7al\u0131\u015fmalar var. Bunlardan bir tanesi Pfizer\/BionTech firmas\u0131n\u0131n 5-12 ya\u015f aras\u0131ndaki \u00e7ocuklara a\u015f\u0131 uygulanmas\u0131n\u0131 kapsayan \u00e7al\u0131\u015fma. Hen\u00fcz yay\u0131mlanmad\u0131, o veriler Amerikan Sa\u011fl\u0131k Otoritesi’ne sunuldu. Sonu\u00e7lar\u0131 g\u00f6rmedik. Gerek Amerikan Sa\u011fl\u0131k Otoritesi gerekse bilimsel bir dergide yay\u0131mlan\u0131p hakem ele\u015ftirisinden ge\u00e7tikten sonra bu konuda daha kesin bir yarg\u0131ya varmak m\u00fcmk\u00fcn. \u00d6n izlenim \u00f6yle ki, bu ya\u015f grubunda a\u015f\u0131 etkili ve takip s\u00fcresi i\u00e7erisindeki tabii k\u0131sa s\u00fcreli takip, g\u00fcvenlik ve yan etki a\u00e7\u0131s\u0131ndan ciddi bir sorun yokmu\u015f gibi g\u00f6z\u00fck\u00fcyor. E\u011fer bu kan\u0131tlan\u0131rsa, benzer a\u015f\u0131larla mesela \u00c7in’de yap\u0131lan \u00e7al\u0131\u015fmalar var. Oradaki \u00e7al\u0131\u015fmalarda a\u015f\u0131 ya\u015f\u0131n\u0131n 2 ya\u015fa kadar indi\u011fini g\u00f6r\u00fcyoruz. E\u011fer bunlar da bilimsel olarak kan\u0131tlan\u0131r, ba\u015fka bilim adamlar\u0131n\u0131n ele\u015ftiri s\u00fczgecinden ge\u00e7er ve do\u011fru oldu\u011fu kabul edilirse, o zaman \u00f6yle anla\u015f\u0131l\u0131yor ki k\u0131sa bir s\u00fcre sonra a\u015f\u0131 ya\u015f\u0131n\u0131n 2 ya\u015fa kadar indi\u011fini g\u00f6rebilece\u011fiz. E\u011fer a\u015f\u0131 ya\u015f\u0131 daha da a\u015fa\u011f\u0131 iner ve toplumda yayg\u0131n bir duruma gelirse o zaman pandemi kontrol\u00fcnde \u00f6nemli bir ad\u0131m at\u0131lm\u0131\u015f olacakt\u0131r” diye konu\u015ftu. <\/p>\n
Kaynak: DHA<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"
Hacettepe \u00dcniversitesi T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Murat Akova, Turkovac ile Sinovac’\u0131n e\u015f de\u011fer bir a\u015f\u0131 oldu\u011funu s\u00f6yledi….<\/p>\n","protected":false},"author":2,"featured_media":16450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-16449","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/16449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=16449"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/16449\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/16450"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=16449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=16449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=16449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![](\"https:\/\/istanbulchannel.net\/wp-content\/uploads\/2021\/09\/yerli-asi-mi-cin-asisi-mi-prof-dr-akovadan-turkovac-aciklamasi.webp\")
<\/p>\n